Pfizer agrees to lower prescription drug costs for Medicaid in a deal with President Trump
Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration.
Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration.
President Trump has signed an executive order setting a 30-day deadline for drugmakers to lower the price of prescription drugs or face new limits over what the government will pay.